Table 1.
Source | Prothrombinase complex surface | PL Conc. | FXa Conc. | FVa Conc. | |
---|---|---|---|---|---|
Moyer et al [52] | PC/PS (75/25) | 5.0 μM | 5.0 nM | 5.0 nM | 480 |
Deguchi et al [14] | SkM | - | 0.2 nM | 5.0 nM | 490 |
Zilberman-Rudenko et al [16] | CM | - | 0.2 nM | 5.0 nM | 371 |
Deguchi et al [14] | PC/PS (80/20) | 20 μM | 0.2 nM | 5.0 nM | 396 |
Krishnaswamy et al [51] | PC/PS (75/25) | 30 μM | 1 nM | 4.1 nM | 1,344 |
Bunce et al [53] | Platelet (1×108/mL) | 0.1 nM | 10 nM | 560 |
kcat (Vmax/[FXa]) values for SkM, CM, phospholipids, and activated platelets are summarized. For comparisons in this Table, note that experimental conditions included modest variations, inter alia, in assay buffer contents (Tris vs. HEPES, 2 mM vs. 5 mM CaCl2 concentrations, etc.), different temperatures and different phospholipid (PC/PS) ratios. See references [14, 51–53] for details about differences in assay contents and conditions. This Table is modified from previous papers [14, 16]. Abbreviations: PL, phospholipid; FXa, Factor Xa; FVa, Factor Va; PC/PS, phosphatidylcholine/phosphatidylserine.